-
Loading metrics
Open Access
Peer-reviewed
Research Article
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles
-
Xiaoquan Li ,
Contributed equally to this work with: Xiaoquan Li, Peter V. Lidsky, Yinghong Xiao
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliations Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America
⨯ -
Peter V. Lidsky ,
Contributed equally to this work with: Xiaoquan Li, Peter V. Lidsky, Yinghong Xiao
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America
⨯ -
Yinghong Xiao ,
Contributed equally to this work with: Xiaoquan Li, Peter V. Lidsky, Yinghong Xiao
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America
⨯ -
Chien-Ting Wu,
Roles Investigation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Department of Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, California, United States of America
⨯ -
Miguel Garcia-Knight,
Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America
⨯ -
Junjiao Yang,
Roles Investigation
Affiliations Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America
⨯ -
Tsuguhisa Nakayama,
Roles Investigation
Affiliation Department of Otolaryngology–Head and Neck Surgery, Stanford University, Stanford, California, United States of America
⨯ -
Jayakar V. Nayak,
Roles Resources
Affiliation Department of Otolaryngology–Head and Neck Surgery, Stanford University, Stanford, California, United States of America
⨯ -
Peter K. Jackson,
Roles Resources
Affiliation Department of Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, California, United States of America
⨯ -
Raul Andino ,
Roles Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing
* E-mail: raul.andino@ucsf.edu (RA); xiaokun.shu@ucsf.edu (XS)
Affiliation Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America
⨯ -
Xiaokun Shu
Roles Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: raul.andino@ucsf.edu (RA); xiaokun.shu@ucsf.edu (XS)
Affiliations Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America
⨯
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles
- Xiaoquan Li,
- Peter V. Lidsky,
- Yinghong Xiao,
- Chien-Ting Wu,
- Miguel Garcia-Knight,
- Junjiao Yang,
- Tsuguhisa Nakayama,
- Jayakar V. Nayak,
- Peter K. Jackson,
- Raul Andino
-
- Published: September 3, 2021
- https://doi.org/10.1371/journal.ppat.1009898